Lucid Company Profile (OTCMKTS:LCDX)

About Lucid (OTCMKTS:LCDX)

Lucid logoLucid, Inc., doing business as Caliber Imaging & Diagnostics, Inc., is a medical technologies company that designs, develops and markets imaging solutions that shows tissue at the cellular level. The Company offers in-vivo confocal microscopes designed for imaging skin and other tissue. The Company is engaged in development of VivaScope, a suite of imaging products. Its telepathology system allows near real-time collaboration with remote specialists. Its RS-G4 Upright Research Confocal Microscope is used to locate a data collection area on a large specimen, such as a whole brain section. Its specialty confocal microscopes include VivaScope 3000, which is capable of imaging cells in the epidermis of skin and the fibrous tissue, primarily collagen and fibrin, in the dermis, and VivaScope 1500, which provides non-invasive, in vivo images of the epithelium and supporting stroma. Its clinical solutions include VivaScope 1500, VivaScope 3000, VivaNet and VivaScan.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:LCDX
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $9.89 million
  • Outstanding Shares: 8,384,000
Average Prices:
  • 52 Week Range: $0.40 - $1.60
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Sales & Book Value:
  • Annual Revenue: $3.14 million
  • Price / Sales: 3.15
  • Book Value: ($1.69) per share
  • Price / Book: -0.70
Profitability:
  • EBIDTA: ($5,460,000.00)
Misc:
  • Average Volume: 4,062 shs.
 

Frequently Asked Questions for Lucid (OTCMKTS:LCDX)

What is Lucid's stock symbol?

Lucid trades on the OTCMKTS under the ticker symbol "LCDX."

Who are some of Lucid's key competitors?

How do I buy Lucid stock?

Shares of Lucid can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Lucid stock cost?

One share of Lucid stock can currently be purchased for approximately $1.18.

Analyst Ratings

Consensus Ratings for Lucid (OTCMKTS:LCDX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Lucid (OTCMKTS:LCDX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Lucid (OTCMKTS:LCDX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Lucid (OTCMKTS:LCDX)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Lucid (OTCMKTS:LCDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Lucid (OTCMKTS:LCDX)
Insider Trades by Quarter for Lucid (OTCMKTS:LCDX)
Insider Trades by Quarter for Lucid (OTCMKTS:LCDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2014Northeast Lcd Capital, LlcMajor ShareholderBuy24,468,808$0.55$13,457,844.40View SEC Filing  
7/31/2014Paul StukaDirectorBuy1,101,230$0.55$605,676.50View SEC Filing  
6/5/2014L. Michael HoneCEOBuy200,000$1.00$200,000.00View SEC Filing  
12/3/2013Kevin M CroninDirectorBuy21,000$0.80$16,800.00View SEC Filing  
11/18/2013Kevin M CroninDirectorBuy4,500$1.02$4,590.00View SEC Filing  
11/15/2013Kevin M CroninDirectorBuy2,000$0.95$1,900.00View SEC Filing  
8/22/2013Kevin M CroninDirectorBuy3,750$0.78$2,925.00View SEC Filing  
8/20/2013Kevin M CroninDirectorBuy5,000$1.00$5,000.00View SEC Filing  
8/16/2013Kevin M CroninDirectorBuy7,500$1.00$7,500.00View SEC Filing  
8/14/2013Kevin M CroninDirectorBuy25,500$0.98$24,990.00View SEC Filing  
6/14/2013Kevin M CroninDirectorBuy6,000$0.98$5,880.00View SEC Filing  
6/7/2013Kevin M CroninDirectorBuy16,750$0.80$13,400.00View SEC Filing  
12/18/2012William J SheaDirectorBuy214,286$1.40$300,000.40View SEC Filing  
11/28/2012William J SheaDirectorBuy40,000$1.39$55,600.00View SEC Filing  
11/27/2012William J SheaDirectorBuy111,000$1.41$156,510.00View SEC Filing  
11/20/2012William J SheaDirectorBuy9,000$1.50$13,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Lucid (OTCMKTS:LCDX)
Latest Headlines for Lucid (OTCMKTS:LCDX)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social

Chart

Lucid (LCDX) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff